title: Antimicrobials at the End of Life: An Opportunity to Improve Palliative Care and Infection Management.
authors.affiliation: Yale School of Medicine, Section of Infectious Diseases, Department of Internal Medicine, New Haven, Connecticut.
authors.forename: Manisha
authors.initials: M
authors.lastname: Juthani-Mehta
authors.affiliation: University of Michigan Health System, Division of Infectious Diseases, Department of Internal Medicine, Ann Arbor3Associate Editor, JAMA.
authors.forename: Preeti N
authors.initials: PN
authors.lastname: Malani
authors.affiliation: Hebrew SeniorLife Institute for Aging Research, the Department of Medicine, Beth Israel Deaconess Medicine Center, Boston, Massachusetts5Department of Medicine, Harvard Medical School, Boston, Massachusetts.
authors.forename: Susan L
authors.initials: SL
authors.lastname: Mitchell
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy*; D003657:Decision Making; D006801:Humans; D018570:Risk Assessment; D013727:Terminal Care / Q000379:methods*; D019452:Terminally Ill
chemical_list: D000900:Anti-Bacterial Agents